Recent Articles from Business Wire

The Federal Home Loan Bank of Chicago (FHLBank Chicago) today announced its preliminary and unaudited financial results for the third quarter of 2026.

Elucid Bioimaging Inc. (“Elucid”) today reaffirmed its commitment to advancing its mission – the prediction and personalization of the prevention of heart attack and stroke – and its confidence in the technology and intellectual property behind its products.

Liquid Strategies announced the launch of the Overlay Shares Nasdaq 100 Income ETF (OVQ), an actively managed ETF that combines Nasdaq-100 equity exposure with a put-spread options strategy designed to seek to generate income. This is the latest addition to Liquid Strategies’ longstanding experience managing option overlay strategies across the Overlay Shares ETF suite since 2019.

Infinity (Infinity Artificial Intelligence Institute), an automated AI research company building the software layer that makes any AI chip inference-ready, today announced two key hires to its engineering team. Aditya Om, a former senior software engineer at Meta Superintelligence Labs (MSL), joins Infinity as Staff Inference Optimization Engineer, and Elliot Arledge, whose CUDA and LLM coding courses have taught skills to more than two million people, joins as Member of Technical Staff.

PennyMac Mortgage Investment Trust (NYSE: PMT) will announce results for the quarter ended September 30, 2026, in a news release to be issued after the market close on Thursday, October 29, 2026. The conference call and live audio webcast is being rescheduled to 6:30 pm. Eastern Time from the originally scheduled 6:00 p.m. Eastern Time.

KBRA assigns preliminary ratings to five classes of notes issued by Foundation Finance Trust 2026-2 (“FFIN 2026-2”), an asset-backed securitization collateralized by unsecured consumer loans primarily used for home improvements.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below.

AM Best has affirmed the Financial Strength Rating (FSR) of B++ (Good) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb+” (Good) of The Hand-in-Hand Mutual Fire Insurance Company Limited (HIHF) (Guyana). The outlook of the FSR is stable while the outlook of the Long-Term ICR is negative. Concurrently, AM Best has affirmed the FSR of B++ (Good) and the Long-Term ICR of “bbb” (Good) of Hand-in-Hand Mutual Life Assurance Company Limited (HIHL) (Guyana). The outlooks of these Credit Ratings (ratings) are negative. Both entities are collectively referred to as Hand-in-Hand Group.

PennyMac Financial Services, Inc. (NYSE: PFSI) will announce results for the quarter ended September 30, 2026, in a news release to be issued after the market close on Thursday, October 29, 2026. The conference call and live audio webcast is being rescheduled to 5:30 pm. Eastern Time from the originally scheduled 5:00 p.m. Eastern Time.

NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, today announced Anthony Palladino as Chief Financial Officer.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner Roche announced today late-breaking oral presentation data from the ongoing Phase 3 IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 - 52.0, P<0.0001), relative to placebo at 37 weeks, as measured by 24-hour urine protein-to-creatinine ratio (UPCR). Proteinuria is a key indicator of kidney damage and a reduction in UPCR is strongly associated with the preservation of long-term kidney function. Results presented at the American Society of Nephrology (ASN) Kidney Week 2026 also showed that, among patients with baseline hematuria (blood in urine), a greater proportion of patients achieved hematuria resolution at Week 37 with sefaxersen versus placebo.

The board of directors of Macy's, Inc. (NYSE: M) today declared a regular quarterly dividend of 19.15 cents per share on Macy's, Inc.’s common stock, payable on January 4, 2027, to shareholders of record at the close of business on December 15, 2026.

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today late-breaking oral presentation data from the ongoing Phase III IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 - 52.0, P<0.0001), relative to placebo at 37 weeks, as measured by 24-hour urine protein-to-creatinine ratio (UPCR). Proteinuria is a key indicator of kidney damage and a reduction in UPCR is strongly associated with the preservation of long-term kidney function. Results presented at the American Society of Nephrology (ASN) Kidney Week 2026 also showed that, among patients with baseline hematuria (blood in urine), a greater proportion of patients achieved hematuria resolution at Week 37 with sefaxersen versus placebo.

The Capital Corporation (“TCC”, www.thecapitalcorp.com) is pleased to announce that it served as the exclusive investment banking advisor to Champion Coach, Inc. (“Champion Coach” or the “Company”) in its partnership with Hoffmann Family of Companies (“HF Companies”).

Building on decades of holding pharmaceutical companies responsible for dangerous products and unlawful business practices, The Lanier Law Firm played a pivotal role supporting Texas Attorney General Ken Paxton in securing a $45 million settlement with Gilead Sciences, Inc. Announced on Oct. 22, the settlement resolves claims that the company offered illegal incentives to medical providers to prescribe its drugs over competitors’ medications.

Investors in Bank Of America Corporation ("Bank of America" or the "Company") (NYSE: BAC) have until December 15, 2026 to ask the Court to appoint them lead plaintiff in a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired Bank Of America Corporation securities between August 1, 2025 and October 13, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today reminded investors of the upcoming deadline. The Bank Of America Corporation case, New England Teamsters Pension Fund v. Bank of America Corporation et al., was filed on October 16, 2026 and is pending in the U.S. District Court Southern District of New York (Case No. 1:26-cv-09137).

Lyntris Inc. (NYSE: LYNX), a defense technology company delivering integrated sensing, communications, and mission systems, today announced it will issue financial results for the third quarter fiscal year 2026 on Wednesday, November 4, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 PM Eastern Time.

Robbins Geller Rudman & Dowd LLP announces that purchasers of Duolingo, Inc. (NASDAQ: DUOL) Class A common stock between May 2, 2025 and February 26, 2026, both dates inclusive (the “Class Period”), have until December 7, 2026 to seek appointment as lead plaintiff of the Duolingo class action lawsuit. Captioned City of Dearborn Heights Act 345 Police & Fire Retirement System v. Duolingo, Inc., No. 26-cv-02199 (W.D. Pa.), the Duolingo class action lawsuit charges Duolingo as well as certain of Duolingo’s current and former executive officers with violations of the Securities Exchange Act of 1934.

Millrose Properties, Inc. ("Millrose" or the "Company") (NYSE: MRP) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 8, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 7, 2025 through October 2, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Rubenstsein et al. v. Millrose Properties, Inc. et al., which was filed on October 9, 2026 in the U.S. District Court for the Southern District of Florida (Case No. 9:26-cv-81386).

KBRA assigns preliminary ratings to 96 classes of mortgage pass-through certificates from Chase Home Lending Mortgage Trust 2026-JINV2 (CHASE 2026-JINV2), a prime investor RMBS transaction comprising 327 residential mortgages with an aggregate interest-bearing principal balance of approximately $398.8 million as of the October 1, 2026 cut-off date. The underlying pool primarily consists of loans that are collateralized by investment properties (94.7%). The pool is characterized by substantial borrower equity in each mortgaged property, as evidenced by the WA original CLTV of 72.5%. The weighted average original credit score is 778, which is well within the prime mortgage range.

Palleon Pharmaceuticals, a clinical-stage biotechnology company developing glycan editing therapeutics for autoimmune disease and cancer, today announced Phase 2 results for HLX79/E-602 (efgitasialase alfa), a first-in-class sialidase-Fc fusion protein, in primary membranous nephropathy (pMN).

Pilot is proud to honor veterans and active-duty service members with a free meal on Veterans Day and invites guests to round up purchases to help veterans transition to civilian careers.

The Chemours Company ("Chemours" or the "Company") (NYSE: CC) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 7, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 20, 2026 through August 4, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Darcy v. The Chemours Company et al., which was filed on October 8, 2026 in the U.S. District Court District of Delaware (Wilmington) (Case No. 1:26-cv-01299).

Today, the Council for Citizens Against Government Waste (CCAGW) announced its endorsement of 12 candidates for the U.S. Senate, 123 candidates for the U.S. House of Representatives, and six candidates for governor. The candidates have been endorsed based on their lifetime rating in CCAGW’s 2025 Congressional Ratings.

Popular, Inc. (NASDAQ: BPOP) announced today that its Board of Directors has approved a quarterly cash dividend of $0.90 per share on its outstanding common stock. The dividend will be payable on January 4, 2027 to shareholders of record at the close of business on November 13, 2026.

Cirrus (Cirrus Aircraft Ltd.), the global leader in Personal Aviation™, broke ground on the 15,000-square-foot Engine Run-Up Center, designed to safely and efficiently test SR Series, Vision Jet®, and TRAC10 engine system functionality, performance, and fuel calibration as part of the aircraft certification process. Cirrus will invest over $8 million in the facility, which will provide a centralized, enclosed, well-equipped, climate-controlled building year-round. The Run-Up Center is expected to be completed and operational in summer 2027.

KBRA assigns preliminary ratings to five classes of notes issued by BHG Securitization Trust 2026-3CON (“BHG 2026-3CON”), an asset-backed securitization collateralized by a pool of unsecured consumer loans (“Consumer Loans”).

Antares today announced that the U.S. Department of Energy (DOE) has approved the Nuclear Safety Design Agreement (NSDA) for Mark-1, the company's first electricity-producing reactor. The approval is the first step in DOE's authorization pathway for Mark-1 and establishes the design requirements, safety analysis approach, and regulatory expectations that will govern the reactor through construction and operation.

Green Plains Inc. (NASDAQ:GPRE) will release third quarter 2026 financial results after the market closes on November 5, 2026, and then host a conference call beginning at 4:30 p.m. Eastern time (3:30 p.m. Central time) to discuss the results and outlook.

A securities class action lawsuit has been filed against D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) on behalf of investors who purchased or otherwise acquired D-Wave Quantum, Inc. securities from February 26, 2026 to August 25, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Fessler v. D-Wave Quantum, Inc. et al., filed on October 15, 2026 in the U.S. District Court California Northern District (Case No. 3:26-cv-11953). Lead plaintiff motions in the D-Wave Quantum, Inc. case are due by December 15, 2026.

Genmab A/S (Nasdaq: GMAB) announced today positive topline results from the global Phase 3 RAINFOL™-02 trial of rinatabart sesutecan (Rina-S®), an investigational folate receptor alpha (FRα)-targeted, topoisomerase I (TOPO1)-inhibitor antibody-drug conjugate (ADC), in patients with platinum-resistant ovarian cancer (PROC) regardless of FRα expression level or prior treatment with mirvetuximab. The trial met its primary endpoint of progression-free survival (PFS), with Rina-S demonstrating a statistically significant and clinically meaningful improvement compared with investigator’s choice chemotherapy in the intent-to-treat (ITT) and in the primary analysis set (PAS) populations.

AM Best has revised the outlooks to stable from negative and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) of Medical Professional Mutual Insurance Company (Boston, MA) and its rating unit members, collectively known as Coverys Companies (Coverys). (See below for a detailed list of these subsidiaries and Credit Ratings [ratings]).

Western Alliance Bank hosted its first Western Alliance 100, an invitation-only CEO strategic forum in Phoenix that brought together top clients and business leaders from across the country to explore the forces shaping business decisions and the opportunities ahead. President George W. Bush joined Western Alliance Chairman, President and CEO Kenneth Vecchione for a moderated conversation, while Duke’s legendary Coach K and experts in markets, technology and demographic shifts also shared their viewpoints on key issues facing business leaders today.

Worthington Steel, Inc. (NYSE: WS) today announced that the proposed domination and profit and loss transfer agreement (“DPLTA”) between Kloeckner & Co SE (“Kloeckner”) and Worthington Steel GmbH, a wholly owned indirect subsidiary of Worthington Steel, did not receive the required shareholder approval at Kloeckner’s extraordinary general meeting in Düsseldorf, Germany. As a result, the DPLTA will not become effective. Worthington Steel remains committed to delivering on the long-term strategic and economic rationale of the transaction. For now, the company will operate within the existing ownership and governance structure and will pursue commercial, procurement, operational and strategic opportunities that can be advanced within that framework and in accordance with applicable law.

Hundreds of New Yorkers gathered at the Edison Ballroom on October 22, marking the 15th anniversary of Ronald McDonald House New York’s (RMH-NY) Board of Associates (BoA). The Annual Soirée brought together young professionals, alumni and supporters to celebrate the Board’s longstanding commitment to children and families facing pediatric cancer and other serious illnesses.

Mitsubishi Power Americas, Inc. today announced plans to expand its Savannah Machinery Works facility, a key U.S. manufacturing and service center for advanced-class gas turbines, steam turbines and power generation equipment serving customers across the Americas. The expanded facility will accelerate Mitsubishi Power’s ability to meet unprecedented power generation needs, with one location that combines advanced manufacturing, a skilled regional workforce and shipping, with port and rail access at the intersection of I-95 and I-16.

Customer platform Planhat today announced it has been recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Customer Success Management Platforms for the third consecutive year. The recognition follows a period of rapid innovation for Planhat, with the recent launch of Pi, the world’s first multiplayer customer agent. Pi works alongside entire account teams, drawing on shared context to run core commercial processes from sales and renewals to implementations and support.

Perfect Corp. (NYSE: PERF), a global leader in augmented reality (AR) and artificial intelligence (AI) beauty and fashion tech, today announced that YouCam is one of the first platforms to integrate the newly released Kling 4.0 API. The newest AI video model from Kuaishou Technology’s Kling AI is now live across the YouCam lineup on mobile and web. Built for longer storytelling, Kling 4.0 lets users set up to 10 keyframes instead of only a first and last frame, then generates up to 30 seconds of continuous video with lip-synced dialogue and stereo sound in a single pass.

AEG Presents, a global leader in live entertainment, announced today that Chris Hammond will take on the role of Senior Vice President of the Pacific Northwest. Hammond, most recently a VP of Talent at the promoter’s Las Vegas office, will now oversee booking and operational strategy for AEG Presents’ growing portfolio of Pacific Northwest venues. He will be based in Seattle and report to President of North American Regional Offices, Brent Fedrizzi.

Investors who lost money on Moderna, Inc. ("Moderna" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Moderna, Inc. (NASDAQ: MRNA) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding Moderna, Inc.

Investors who lost money on FirstCash Holdings, Inc. ("FirstCash" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of FirstCash Holdings, Inc. (NASDAQ: FCFS) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding FirstCash Holdings, Inc.

Investors who lost money on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Integra LifeSciences Holdings Corporation (NASDAQ: IART) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 2, 2026 disclosure regarding Integra LifeSciences Holdings Corporation.

Investors who lost money on Carpenter Technology Corporation ("Carpenter Technology" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Carpenter Technology Corporation (NYSE: CRS) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding Carpenter Technology Corporation.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced initial results from the Company’s Phase 1 study evaluating azercabtagene zapreleucel (azer-cel), an investigational, allogeneic CD19-directed chimeric antigen receptor (CAR) T-cell therapy, in patients with progressive multiple sclerosis (MS). The data represent the first reported clinical evaluation of an allogeneic CD19-directed CAR T-cell therapy in progressive MS and were presented in a late-breaking oral session at MSToronto2026, the 10th Joint Meeting of the Americas and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS), being held October 21–23, 2026, in Toronto, Canada.

Dashen Bank and ShebaMiles have launched a Platinum co-branded Mastercard debit card in Ethiopia, combining secure payments, digital access, loyalty benefits and premium travel privileges in one offering.

Bristol Myers Squibb (NYSE: BMY) today announced disclosure of interim safety and efficacy results from the multiple sclerosis (MS) cohorts of the Phase 1, single-arm, dose-escalation Breakfree-2 study evaluating zolacabtagene autoleucel (zola-cel; BMS-986353), an investigational, autologous CD19-directed CAR T cell therapy, in patients with highly active relapsing MS (haRMS) and progressive forms of MS (PMS). The data are being presented today in an oral presentation (Abstract #1615) at MSToronto 2026, the 10th Joint ACTRIMS-ECTRIMS Meeting taking place in Toronto, Canada.

At the 2026 eClinicalWorks and healow National Conference, eClinicalWorks®, one of the largest privately held healthcare technology companies in the United States, and healow®, a leading provider of patient engagement and AI-powered healthcare solutions, expect to report revenues exceeding $1.3 billion for 2026.

Insurity, a leading provider of cloud-based software for insurance carriers, brokers, and MGAs, today announced that its largest Excellence in AI & Insurance conference to date highlighted the next generation of intelligent insurance technology and its potential to transform how insurers operate and grow. Held October 5–7 in Fort Lauderdale, Florida, Excellence in AI & Insurance brought together insurance executives, technology leaders, and industry experts to explore the real-world applications of AI and strategies for improving business performance.

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79).

Right Lane Industries ("RLI"), a long-term industrial holding company, today announced that it has completed the sale of Bold Renewables, LLC ("Bold") to Integrated Power Services ("IPS"). Financial terms of the transaction were not disclosed.

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania.

In its 18th year, the Skechers Foundation, Skechers Pier to Pier Friendship Walk and presenting sponsor Nickelodeon raised a record-breaking $3.3 million for children with special needs and education. Supported by boxing legend Sugar Ray Leonard, celebrity TV host Brooke Burke, actor Nate Simon and baseball icons Chris Taylor, Kyle Karros and Jared Karros, thousands gathered on Sunday for the heartwarming annual tradition of the pier-to-pier walk in Southern California’s South Bay.

SCG (SaaS Consulting Group), a business transformation partner serving more than 280 mid-market and private equity-backed companies, today announced the appointment of Tim Dietrich as its first Head of AI, a newly created global role that puts artificial intelligence at the center of the company’s strategy, solutions, and service delivery.

Archimedes, the nationwide leader in specialty drug management solutions, announced today that it will offer proven strategies for addressing rising specialty-drug costs to the more than 500 plan-sponsor clients of Employers Health.

Travel + Leisure Co. (NYSE: TNL), a leading leisure travel company, today announced its purchase of The Cedars Ranch in Wimberley, Texas, which it will rebrand to Eddie Bauer Adventure Club – Texas Hill Country, the first “Outpost” in the Eddie Bauer Adventure Club portfolio. The 20-acre property sits among mature live oaks in the heart of Texas Hill Country, less than an hour outside Austin. Reservations for vacation club owners and guests will open in early 2027, with stays anticipated to begin in summer 2027 at the new Outpost’s 21 accommodations, including geodomes, yurts and cabins. Plans are also in development to expand the property in a future phase.

KBRA releases its quarterly report highlighting our Chief Markets Strategist Van Hesser’s view on key economic indicators, as well as what he identifies as the most influential factors driving credit markets in the upcoming quarter. The report also examines credit market valuations in the context of current and future market conditions.

AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of Al Fujairah National Insurance Company PJSC (AFNIC) (United Arab Emirates) [UAE]. The outlook of these Credit Ratings (ratings) is stable.

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Bank of China Group Insurance Company Limited (BOCG Insurance) (Hong Kong). The outlook of these Credit Ratings (ratings) is stable.

JBS N.V. (NYSE: JBS; B3: JBSS32) announced today that it will release its third quarter 2026 financial results after the U.S. market closes on Monday, November 9, 2026.

DentalXChange, a leading provider of revenue cycle management for the dental industry, is proud to announce Scott Hampel as President. This strategic addition to the Executive Leadership Team reflects DentalXChange’s commitment to growth, innovation, and excellence in service to its clients, partners, and stakeholders.

Hunt Military Communities (HMC) today joined Navy and Department of War leaders, elected officials, and community partners to celebrate the closing of Homeport Hampton Roads Phase II, a $1.7 billion development program with the Department of the Navy that will construct approximately 5,470 new beds and improve or integrate approximately 2,600 existing beds for unaccompanied Sailors at Naval Station Norfolk, Joint Expeditionary Base Little Creek, Naval Air Station Oceana, and in downtown Newport News. Financial close was achieved on September 29, 2026. Combined with the existing Phase I portfolio, the completed project will provide approximately 11,760 beds under a single integrated structure.

Oregon Bancorp, Inc. (OTCBB: ORBN) (the “Company”), parent company of Willamette Valley Bank, reported net income of $746 thousand, or $0.30 per share, for the third quarter of 2026, compared to net income of $604 thousand, or $0.24 per share, for the second quarter of 2026. The Company generated a return on average assets of 0.6% and a return on average equity of 4.0% for the quarter. Third-quarter results included $212 thousand of trailing expenses associated with the closure of the Mortgage Department and $733 thousand of merger-related expenses.

Health Information Alliance, Inc. (HIA) — the operating entity charged with running Connecticut’s Health Information Exchange (HIE), Connie — today announced that Michelle Puhlick will become interim executive director and chief operating officer effective immediately, succeeding Jenn Searls, who is stepping down as part of an established succession plan. Puhlick has served as the organization’s chief operating officer since Connie’s inception in 2021.

Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced presentation of preclinical data at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain, in a poster entitled “Characterising the efficacy of multi-node PI3K/AKT/mTOR pathway inhibition with serabelisib and sapanisertib (PIKTOR) in combination with SERDs and a CDK4/6 inhibitor in models of HR+/HER2- breast cancer.”

Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation radiopharmaceuticals for the treatment of cancer, today announced compelling results from Part 2 of the Phase 2 CONVERGE-01 study evaluating Ac-225 rosopatamab tetraxetan (CONV01-α) in patients with Lu-PSMA-naïve, androgen pathway modulator-resistant (APMR) prostate cancer. In the study, CONV01-α demonstrated potent anti-tumor activity, including deep prostate specific antigen (PSA) responses following a two-dose regimen, with a favorable safety profile.

Ascend Markets, LLC, a wholly owned subsidiary of PSG Digital Labs, Inc. (“Ascend”), and M1X Global today announced the successful completion of the first institutional repurchase agreement (repo) on the Stellar network. The transaction utilized USDM1, a US dollar-denominated sovereign bond issued natively onchain and secured 1:1 by short-duration US Treasuries, and marks a milestone in bringing institutional secured financing onto the Stellar network, one of the longest-running public blockchains, expanding the network’s established payments and transfer infrastructure into programmable repo markets.

Formula 1 and Consumable today announced the launch of the F1 Audio Network, an audio extension of Formula 1 media. The network gives brands a new way to reach racing’s growing fanbase through premium, sound-on ad experiences across mobile apps and an extended audio ecosystem.

CBB Bancorp, Inc. (the "Company') (OTCQX: CBBI) announced that its Board of Directors declared a quarterly cash dividend of $0.15 per common share. The dividend is payable on November 27, 2026, to all stockholders of record as of the close of business on November 13, 2026.

Rock musician Mitch Malone today released his debut solo album, Dreams of Fire. The seven-track album revisits songs conceived in the early 2000s, reimagined to reflect Malone's evolution as a musician.

The U.S. industrial new lease count index has returned to its historical peak, while the renewal index has fallen, according to data from CoStar, the leading global provider of online real estate marketplaces, information and analytics in the property markets.

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market.

ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, today announced a native integration with Exa, the search API for AI agents. Mutual customers can bring ZoomInfo GTM Intelligence into Exa through Exa Connect, and developers can build apps that pull the same data through the GTM.AI API and Model Context Protocol (MCP) server.

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Neuromodulation: Technology at the Neural Interface has published the full 36-month results from the CORE-VNS study, the first long-term effectiveness evaluation of contemporary VNS Therapy™ devices in people with Drug-Resistant Epilepsy (DRE). The article, “CORE-VNS Seizure and Non-Seizure 36 Month Outcomes in People with Drug-resistant Epilepsy,”1 reports findings from the full international CORE-VNS cohort, providing one of the most extensive evaluations of long-term outcomes associated with contemporary VNS Therapy in people with DRE.

On October 8, 2026, Striding AI unveiled its Physical AI solution for retail, including two self-developed robots and a robot management platform, at the 22nd Asia-Pacific Retailers Convention & Exhibition (APRCE 2026).

Investors who suffered losses on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Integra LifeSciences Holdings Corporation (NASDAQ: IART) investors into whether the Company may have violated the federal securities laws. The investigation comes after a October 2, 2026 disclosure concerning Integra LifeSciences Holdings Corporation.